Patent · US Active

Haemostatic composition comprising crystalline polyphosphate

US9907879B2 · kind B2 · utility

1Cited by

3References

14Claims

0Family size

Assignee

BK GIULINI GMBH · DE

Inventors

Henrike Thauern · Mannheim, DE
Thomas Staffel · Grünstadt, DE

Key dates

Filing date	Oct 30, 2014
Grant date	Mar 6, 2018
Priority date	—
Expiry date	Nov 4, 2034

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61L2400/04
WIPO fieldMedical technology
WIPO sectorInstruments

Abstract

The present invention relates to the use of polyphosphate in crystalline form for treatment of wounds, especially bleeding wounds, wherein the anion of the polyphosphate has a (numerical) average of at least 4 phosphorus atoms per polyphosphate anion. The invention additionally relates to a composition suitable for treatment of wounds, especially bleeding wounds, comprising an inventive polyphosphate and a carrier material. The invention further provides a method suitable for production of the inventive composition, which comprises the introduction of the polyphosphate and optionally further haemostatic agents into the carrier material, or into a component or into a precursor of the carrier material.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.